The emerging therapy of the medication represents a exciting advance in the handling of the condition. Unlike existing therapies, tirzepatide impacts dual pathways – glucagon-like peptide-1 (GLP-1) and the GIP https://tirzepatidepeptide185600.blogdon.net/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-58183743